Tele-Pulmonary Rehabilitation for COPD in Peripheral Areas
Official title: Examining the Feasibility and Effectiveness of a Remote Group Respiratory Rehabilitation Program for Patients With Chronic Obstructive Pulmonary Disease Living in Peripheral Areas as a First Step to Policy Change
Run by Tel-Aviv Sourasky Medical Center · NCT07666854 · Data updated 2026-11-12
This study tests whether a group tele-rehab program for COPD patients living in peripheral areas helps people start and stick with pulmonary rehabilitation better than usual referral to in-person PR.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 40 Years and up |
| Sex | All |
| Enrollment | 110 (estimated) |
| Sponsor | Tel-Aviv Sourasky Medical Center Government |
| Locations | 1 site (Tel Aviv) |
| Status | Recruiting |
| Started | July 1, 2026 |
| Main results expected | July 1, 2028 |
| Study ends | August 1, 2028 |
| Registry record updated | September 24, 2026 |
| Trial ID | NCT07666854 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults with COPD who are eligible for pulmonary rehabilitation under Israeli health basket criteria, live in peripheral areas, and are willing and able to use tele-rehabilitation tools.
✕Probably not a fit
Patients who cannot operate the mobile app or lack a compatible device, or who have contraindicated conditions or recent PR completion may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This prospective randomized trial compares group-based tele-pulmonary rehabilitation to usual care (referral to standard PR) for COPD patients living in peripheral areas. Participants are followed for 12 months with periodic assessments of PR initiation, adherence, safety, symptoms, exacerbations, lung function, functional tests, and health-related quality of life. Outcomes include COPD symptom burden, quality of life, anxiety/depression, knowledge about COPD, and patient satisfaction. The study uses baseline demographic and clinical data, monthly to semi-annual follow-ups, and patient-reported outcomes to gauge feasibility, effectiveness, and acceptability of tele-rehabilitation. Eligibility focuses on adults with COPD eligible for PR under Israeli health basket criteria and residing in peripheral regions.
Why it matters
Potential benefit: If successful, patients in peripheral areas could gain easier access to rehabilitation and experience better adherence and outcomes related to COPD.
How similar studies have gone: Prior studies suggest tele-rehabilitation can improve access and adherence in COPD, though the effectiveness of a group-based tele-rehab approach in peripheral populations requires further evidence.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Male and females Patients with COPD based on accepted criteria who are eligible for reimbursement of pulmonary rehabilitation (PR) according to the Israeli "health basket" criteria including one of the following: * FEV1 below 50% * Severe exacerbation (hospitalization) in the previous year * Two moderate exacerbations in the previous year * Willingness to initiate a PR or TPR programs. * Living in geographic peripheral area. * Ability to perform the TPR program or traditional PR activities as assessed by a member of the study team prior to enrollment. * Agree to participate, with signed informed consent. * Age \> 18. Exclusion Criteria: * Uncontrolled comorbidity (e.g uncontrolled congestive heart failure). * Inability to operate the mobile application. * Without a mobile device or computer. * An exacerbation in the 2-months prior to randomization. * Completed PR program in the last 12 months. * Pregnancy. * Patients with cognitive impairment.
Where it's running
-
Tel Aviv Sourasky Medical Center
Tel Aviv, Israel Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Enhanced COPD care for people being checked for lung cancer
This project will test whether finding and treating COPD early in people being checked for possible lung cancer helps symptoms, lung function, and overall care.
-
High-Flow Nasal Cannula vs Noninvasive Ventilation in COPD with Hypercapnia
This study tests whether a high-flow nasal cannula can better support gas exchange and comfort compared with noninvasive ventilation in COPD patients with mild-to-moderate elevated CO2.
-
Risk-based lung cancer screening in COPD patients using ML and clinical models
This study tests whether a PLCOm2012 risk model plus a machine learning model can spot COPD patients at high risk for lung cancer to see if they benefit from low-dose CT screening.
-
Biologics for Type 2 Inflammation in Asthma and COPD in Real World
This real-world study tests whether six biologic drugs can reduce flare-ups and improve symptoms in adults with asthma or COPD treated in routine care in China.
-
Nebulized vs handheld maintenance therapy for COPD patients with limited benefit from inhalers
This trial tests whether switching to a breath-enhanced nebulizer with similar COPD meds helps people who don’t get enough relief from their current handheld inhalers.
-
New breathing tests to diagnose airway disease in hospital and community settings
This study tests whether newer breathing tests can correctly diagnose COPD and airway disease as well as standard spirometry, using tests like capnography and oscillometry in hospital and community settings.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.